Markets on Edge: Chips, Earnings, and Insider Exits
August 6 is one of the busiest days of the earnings season. Eli Lilly delivered a standout result, with revenue up 48% driven by GLP-1 drug demand. Analysts responded positively — the consensus target rose to $1,283.…